Andres Biotech Ltd

Odessa, Ukraine

Anabolic steroids, also known more properly as anabolicandrogenic steroids, are steroidal androgens that include natural androgens like testosterone as well as synthetic androgens that are structurally related and have similar effects to testosterone

INTRODUCTIONKryxana 200mg Tablet is used in the treatment of metastatic breast cancer. It helps to slow down the growth of cancer cells and eventually kills them. Kryxana 200mg Tablet is taken in a dose as advised by the doctor. The duration of treatment varies on the basis of your need and response to treatment. You may be asked for regular blood tests while taking this medication. It is better to inform doctor if you notice symptoms of infection like fever, chills and weakness. You should use effective contraception method to prevent pregnancy while taking this medicine It may cause dizziness, so avoid driving or any activity requiring mental focus until you know how it affects you. Neutropenia is a well-recognized adverse effect, in which the number of your white blood cells get reduced and your immune system gets weakened. As a result, you may be at greater risk of getting an infection. However, this side effect disappears rapidly once you stop taking the medicine.USES OF KRYXANA TABLETMetastatic breast cancerSIDE EFFECTS OF KRYXANA TABLETMost side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youre worried about themCommon side effects of KryxanaDecreased white blood cell countNauseaFatigueDiarrheaHair lossConstipationVomitingHeadacheBack painAnemia (low number of red blood cells)HOW TO USE KRYXANA TABLETTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Kryxana 200mg Tablet may be taken with or without food, but it is better to take it at a fixed time.HOW KRYXANA TABLET WORKSKryxana 200mg Tablet is an anti-cancer medication. It works by blocking proteins (kinases) which are important for the growth and division of cells. This slows the growth of cancer cells and eventually kills them.SAFETY ADVICEwarningsAlcoholCONSULT YOUR DOCTORIt is not known whether it is safe to consume alcohol with Kryxana 200mg Tablet. Please consult your doctor.warningsPregnancyCONSULT YOUR DOCTORKryxana 200mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.warningsBreastfeedingCONSULT YOUR DOCTORKryxana 200mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.warningsDrivingUNSAFEKryxana 200mg Tablet may cause side effects which could affect your ability to drive.Some people may experience fatigue, dizziness, or vertigo during treatment with Kryxana 200mg Tablet. If these happen you should be cautious when driving or using machines.warningsKidneyThere is no data available. Please consult doctor before consuming the drug.warningsLiverThere is no data available. Please consult doctor before consuming the drug.

What is Venclexta and how is it used? Venclexta is a prescription medicine used: to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).in combination with azacitidine, or decitabine, or low-dose cytarabine to treat adults with newly-diagnosed acute myeloid leukemia (AML) who:are 75 years of age or older, orhave other medical conditions that prevent the use of standard chemotherapy.It is not known if Venclexta is safe and effective in children. What are the possible side effects of Venclexta? Venclexta can cause serious side effects, including: See "What is the most important information I should know about Venclexta?"Low white blood cell count (neutropenia). Low white blood cell counts are common with Venclexta but can also be severe. Your healthcare provider will do blood tests to check your blood counts during treatment with Venclexta.Infections. Death and serious infections such as pneumonia and blood infection (sepsis) have happened during treatment with Venclexta. Your healthcare provider will closely monitor and treat you right away if you have fever or any signs of infection during treatment with Venclexta.Tell your healthcare provider right away if you have a fever or any signs of an infection during treatment with Venclexta. The most common side effects of Venclexta when used in combination with obinutuzumab or rituximab or alone in people with CLL or SLL include: low platelet countslow red blood cell countsdiarrheanauseaupper respiratory tract infectioncoughmuscle and joint paintirednessswelling of your arms, legs, hands, and feetThe most common side effects of Venclexta in combination with azacitidine or decitabine or low-dose cytarabine in people with AML include: nauseadiarrhealow platelet countsconstipationfever with low white blood cell countslow red blood cell countsinfection in bloodrashdizzinesslow blood pressurefeverswelling of your arms, legs, hands, and feetvomitingtirednessshortness of breathbleedinginfection in lungstomach (abdominal) painpain in muscles or backcoughsore throatVenclexta may cause fertility problems in males. This may affect your ability to father a child. Talk to your healthcare provider if you have concerns about fertility. These are not all the possible side effects of Venclexta. For more information, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA1088. DESCRIPTIONVenetoclax is a selective inhibitor of BCL-2 protein. It is a light yellow to dark yellow solid with the empirical formula C45H50ClN7O7S and a molecular weight of 868.44. Venetoclax has very low aqueous solubility. Venetoclax is described chemically as 4-(4-[2-(4-chlorophenyl)-4, 4- dimethylcyclohex-1-en-1-yl]methylpiperazin-1-yl)-N-(3-nitro-4-[(-2H-pyran-4- ylmethyl)amino]phenylsulfonyl)-2-(1H-pyrrolo[2, 3-b]pyridin-5-yloxy)benzamide) and has the following chemical structure: VENCLEXTA tablets for oral administration are supplied as pale yellow or beige tablets that contain 10, 50, or 100 mg venetoclax as the active ingredient. Each tablet also contains the following inactive ingredients: copovidone, colloidal silicon dioxide, polysorbate 80, sodium stearyl fumarate, and calcium phosphate dibasic. In addition, the 10 mg and 100 mg coated tablets include the following: iron oxide yellow, polyvinyl alcohol, polyethylene glycol, talc, and titanium dioxide. The 50 mg coated tablets also include the following: iron oxide yellow, iron oxide red, iron oxide black, polyvinyl alcohol, talc, polyethylene glycol and titanium dioxide. Each tablet is debossed with V on one side and 10, 50 or 100 corresponding to the tablet strength on the other side.